CXCL17 and endometrial cancer: Colorectal, breast, hepatocellular, and type I endometrial cancer all showed significantly lower levels of CXCL17 mRNA or protein compared to type I endometrial cancer and pancreatic intraductal papillary mucinous carcinoma (Weinstein et al., 2006).